A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer

This trial confirmed that the oral administration of EGCG is an effective and safe method to deal with ARIE. A phase III randomized controlled trial is expected to further corroborate the consequence of EGCG in ARIE treatment.